- 首頁(yè)
- 科研細(xì)胞
- 藥靶模型
-
診斷試劑
腫瘤早篩甲基化標(biāo)準(zhǔn)品
遺傳性基因標(biāo)準(zhǔn)品
優(yōu)生優(yōu)育標(biāo)準(zhǔn)品
HLA標(biāo)準(zhǔn)品
數(shù)字PCR
- 技術(shù)服務(wù)
- 新聞中心
- 資源中心
- 關(guān)于我們
- 聯(lián)系我們
藥靶模型
Drug Target Model
CBP73208
I. Introduction | |
Cell Line Name: | c-Kit Y823D/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II. Background | |
KIT Y823D lies within the protein kinase domain of the Kit protein (UniProt.org). Y823D confers a gain of function on Kit, as indicated by constitutive phosphorylation of Kit in cultured cells (PMID: 14695343, PMID: 20633291). |
|
III. Representative Data | |
1.WB of c-Kit Y823D/BaF3
|
|
2.Sanger of c-Kit Y823D/BaF3
|
|
3. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of BaF3 c-KIT Y823D (C1). |
|
|